Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 50
Sort By: Relevance
Filter
  • 1-17 ل  17 نتائج ل ""Empagliflozin""

فلترة النتائج

Collection : Inserm فلترة بواسطة : موضوع
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Empagliflozin inhibits angiotensin II-induced hypertrophy in H9c2 cardiomyoblasts through inhibition of NHE1 expression

Subjects: Angiotensin II; Cardiomyocyte hypertrophy; Empagliflozin

  • Source: ISSN: 0300-8177.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial

Subjects: Heart failure with reduced ejection fraction; Empagliflozin; Uric acid

  • Source: ISSN: 0195-668X.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Outcomes with empagliflozin in heart failure with preserved ejection fraction using DELIVER‐like endpoint definitions

Subjects: EMPEROR-Preserved; Heart Failure with preserved ejection fraction; Empagliflozin

  • Source: ISSN: 1388-9842 ; European Journal of Heart Failure ; https://hal.univ-lorraine.fr/hal-03797421 ; European Journal of Heart Failure, 2022, 24 (8), pp.1400-1405. ⟨10.1002/ejhf.2558⟩.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Mineralocorticoid Receptor Antagonists and Empagliflozin in Patients With Heart Failure and Preserved Ejection Fraction

Subjects: empagliflozin; heart failure with preserved ejection fraction; hyperkalemia

  • Source: ISSN: 0735-1097.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Empagliflozin and decreased risk of nephrolithiasis: A potential new role for SGLT2 inhibition?

Subjects: Nephrolithiasis; SGLT2 inhibitors; Empagliflozin

  • Source: ISSN: 0021-972X.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Angiotensin II-induced upregulation of SGLT1 and 2 contributes to human microparticle‐stimulated endothelial senescence and dysfunction: protective effect of gliflozins

Subjects: Endothelial senescence and dysfunction; Angiotensin II; Circulating microparticles

  • Source: ISSN: 1475-2840 ; Cardiovascular Diabetology ; https://cnrs.hal.science/hal-03357954 ; Cardiovascular Diabetology, 2021, 20 (1), ⟨10.1186/s12933-021-01252-3⟩.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial

Subjects: Empagliflozin; Health status; Heart failure

  • Source: ISSN: 0195-668X.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure

Subjects: empagliflozin; heart failure; mineralocorticoid receptor antagonists

  • Source: ISSN: 0735-1097.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Mediators of the improvement in heart failure outcomes with empagliflozin in the EMPA‐REG OUTCOME trial

Subjects: Diabetes; Empagliflozin; SGLT2 inhibitor

  • Source: EISSN: 2055-5822 ; ESC Heart Failure ; https://hal.univ-lorraine.fr/hal-03373660 ; ESC Heart Failure, 2021, ⟨10.1002/ehf2.13615⟩

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Empagliflozin Improves Cardiovascular and Renal Outcomes in Heart Failure Irrespective of Systolic Blood Pressure

Subjects: cardiovascular outcomes; empagliflozin; heart failure

  • Source: ISSN: 0735-1097.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction

Subjects: Heart failure; Ejection fraction; Empagliflozin

  • Source: ISSN: 0195-668X.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Concentration‐dependent clinical and prognostic importance of high‐sensitivity cardiac troponin T in heart failure and a reduced ejection fraction and the influence of empagliflozin: the EMPEROR ‐Reduced trial

Subjects: Troponin; Sodium-glucose co-transporter 2 inhibition; Empagliflozin

  • Source: ISSN: 1388-9842 ; European Journal of Heart Failure ; https://hal.univ-lorraine.fr/hal-03717440 ; European Journal of Heart Failure, 2021, 23 (9), pp.1529-1538. ⟨10.1002/ejhf.2256⟩.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat

Subjects: Empagliflozin; SGLT2; Endothelial function

  • Source: ISSN: 1475-2840 ; Cardiovascular Diabetology ; https://cnrs.hal.science/hal-03033762 ; Cardiovascular Diabetology, 2020, 19 (1), ⟨10.1186/s12933-020-00997-7⟩.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR‐Preserved trial

Subjects: Heart failure with preserved ejection fraction; Sodium-glucose co-transporter 2 inhibitors; Empagliflozin

  • Source: ISSN: 1388-9842 ; European Journal of Heart Failure ; https://hal.univ-lorraine.fr/hal-03758946 ; European Journal of Heart Failure, 2020, 22 (12), pp.2383-2392. ⟨10.1002/ejhf.2064⟩.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial

Subjects: cardiorenal outcomes; empagliflozin; [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system

  • Source: ISSN: 0009-7322.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial

Subjects: Trial registration Clinical Trial Registration: URL: https ://www.clini caltr ials.gov. Unique identifier: NCT 01131676 Type 2 diabetes mellitus; Metabolic syndrome; Empagliflozin

  • Source: ISSN: 1475-2840 ; Cardiovascular Diabetology ; https://hal.univ-lorraine.fr/hal-03037621 ; Cardiovascular Diabetology, 2020, 19 (1), pp.200. ⟨10.1186/s12933-020-01174-6⟩.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Cardiovascular Protection by Sodium Glucose Cotransporter 2 Inhibitors: Potential Mechanisms

Subjects: Cardiovascular outcomes; Empagliflozin; Mechanisms

  • Source: ISSN: 0002-9343.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
  • 1-17 ل  17 نتائج ل ""Empagliflozin""